HIGDON LEO I JR
Known title: DirectorCIK: 0001064587
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Citizens Financial Reports Q3 Earnings Beat and Dividend Increase. Citizens Financial Group posted third‑quarter results that topped analysts’ expectations, driven by growth in net interest income. The company also raised its quarterly dividend. Management highlighted the earnings beat during the call and noted the bank’s positioning within the regional banking sector. The results arrived as the stock traded near a key support level.
Transaction History
| EHC | ▲ Buy | Grant | 298 | $0 | 4/18/2022 | View on chart |
| CFG | ▲ Buy | Grant | 130 | $0 | 2/11/2022 | View on chart |
| EHC | ▲ Buy | Grant | 343 | $0 | 1/18/2022 | View on chart |
| EHC | ▼ Sell | Gift | 75,287 | $0 | 12/10/2021 | View on chart |
| EHC | ▼ Sell | Gift | 75,287 | $0 | 12/10/2021 | View on chart |
| CFG | ▲ Buy | Grant | 142 | $0 | 11/12/2021 | View on chart |
| EHC | ▲ Buy | Grant | 311 | $0 | 10/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Encompass Health Sets Q3 2026 Earnings Call Date
Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.
Encompass Health Sets Q3 2026 Earnings Call Date. Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.